• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Arena Pharmaceuticals

Arena Pharmaceuticals

Arena Pharmaceuticals Inc ARNA

Last Price$1.67Day Change (%)3.09%
Open Price$1.62Day Change ($)0.05
Day Range1.62–1.6952-Week Range1.30–5.12

As of Fri 5/27/2016 2:57:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Ulcerative Colitis - Pipeline Review, H1 2016 - Key Players Include Amgen, Gilead Sciences & Celgene Corporation - Research and Markets

    Ulcerative Colitis - Pipeline Review, H1 2016 - Key Players Include Amgen, Gilead Sciences & Celgene Corporation - Research and Markets

  2. Technavio Announces Top Six Vendors in the Global Non-Alcoholic Steatohepatitis Market Until 2020

    Technavio Announces Top Six Vendors in the Global Non-Alcoholic Steatohepatitis Market Until 2020

  3. Global Hypertension Drugs Market 2016-2020 - Key Vendors are Actelion, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo Company, Novartis AG & Sanofi SA - Research and Markets

    Global Hypertension Drugs Market 2016-2020 - Key Vendors are Actelion, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo Company, Novartis AG & Sanofi SA - Research and Markets

  4. Global Equities: What’s Up With Emerging Markets?

    Arena Pharmaceuticals' future depends on its late-stage obesity drug.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.